The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy—which involves ...

Until now, all available treatments, including immunotherapy — which involves strengthening the immune system to fight cancer— have proved disappointing. CAR-T cells are genetically modified immune ...

Combining micropillar deflection analysis, atomic force microscopy, and immunofluorescence staining provides a method for ...

Carbon nanomaterials have rapidly risen as innovative tools in the field of tissue engineering, owing to their exceptional mechanical, electrical, and ...

Ventoux Biosciences is a biotechnology company developing locally delivered therapies for immune-fibrotic diseases. Founded by a patient with Dupuytren's disease and led by seasoned biotech executives ...

Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve ...

The breakdown of perineuronal nets (PNN) in the brain lead to failure to recognize family, friends and caregivers among patients with Alzheimer’s disease (AD), according to an October study published ...

Growing from a single cell into a complex organism with specialized tissues and organs requires a complex and coordinated process.

Researchers from the University of Rochester’s Department of Biomedical Engineering will shed new light on tissue and organ ...

Like all hardworking things, the cytotoxic T lymphocytes (CTLs) of the immune system charged with detecting and destroying ...

Stem cells possess the unique abilities of self-renewal and differentiation into various cell types, making them highly ...